{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:20:42Z","timestamp":1791231642213,"version":"4.1.0"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930114"],"award-info":[{"award-number":["81930114"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304980"],"award-info":[{"award-number":["82304980"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.thromres.2023.08.015","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T02:50:43Z","timestamp":1692931843000},"page":"64-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Recent advances of oxidative stress in thromboangiitis obliterans: biomolecular mechanisms, biomarkers, sources and clinical applications"],"prefix":"10.1016","volume":"230","author":[{"given":"Qi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.thromres.2023.08.015_bb0005","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011214","article-title":"Thromboangiitis obliterans: 110 years old and little progress made","volume":"7","author":"Olin","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"12","key":"10.1016\/j.thromres.2023.08.015_bb0010","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1056\/NEJM200009213431207","article-title":"Thromboangiitis obliterans (Buerger\u2019s disease)","volume":"343","author":"Olin","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.thromres.2023.08.015_bb0015","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1024\/0301-1526\/a000371","article-title":"Thromboangiitis obliterans (Buerger\u2019s disease)","volume":"43","author":"Klein-Weigel","year":"2014","journal-title":"Vasa"},{"issue":"35","key":"10.1016\/j.thromres.2023.08.015_bb0020","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.2174\/0929867326666190816233042","article-title":"Risk factors, mechanisms and treatments of thromboangiitis obliterans: an overview of recent research","volume":"27","author":"Li","year":"2020","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"10.1016\/j.thromres.2023.08.015_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9041036","article-title":"The imbalance among oxidative biomarkers and antioxidant defense systems in thromboangiitis obliterans (Winiwarter-Buerger disease)","volume":"9","author":"Sharebiani","year":"2020","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.thromres.2023.08.015_bb0030","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.avsg.2011.11.005","article-title":"Buerger\u2019s disease","volume":"26","author":"Dargon","year":"2012","journal-title":"Ann. Vasc. Surg."},{"issue":"1","key":"10.1016\/j.thromres.2023.08.015_bb0035","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/1708538112473979","article-title":"Oxidative and antioxidative pathways might contribute to thromboangiitis obliterans pathophysiology","volume":"22","author":"Alamdari","year":"2014","journal-title":"Vascular"},{"key":"10.1016\/j.thromres.2023.08.015_bb0040","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.freeradbiomed.2022.02.004","article-title":"Oxidative stress and regeneration","volume":"181","author":"Jaganjac","year":"2022","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.thromres.2023.08.015_bb0045","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3109\/10409238.2016.1172554","article-title":"The immunoproteasome in oxidative stress, aging, and disease","volume":"51","author":"Johnston-Carey","year":"2015","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"6","key":"10.1016\/j.thromres.2023.08.015_bb0050","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.14336\/AD.2020.0225","article-title":"Oxidative stress at the crossroads of aging, stroke and depression","volume":"11","author":"Shao","year":"2020","journal-title":"Aging Dis."},{"issue":"10","key":"10.1016\/j.thromres.2023.08.015_bb0055","doi-asserted-by":"crossref","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","article-title":"ROS function in redox signaling and oxidative stress","volume":"24","author":"Schieber","year":"2014","journal-title":"Curr. Biol."},{"issue":"1","key":"10.1016\/j.thromres.2023.08.015_bb0060","first-page":"16","article-title":"A review on free radicals and antioxidants","volume":"20","author":"Alkadi","year":"2020","journal-title":"Infect. Disord. Drug Targets"},{"issue":"5","key":"10.1016\/j.thromres.2023.08.015_bb0065","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s11684-019-0729-1","article-title":"Oxidative stress and diabetes: antioxidative strategies","volume":"14","author":"Zhang","year":"2020","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.thromres.2023.08.015_bb0070","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11657-020-00854-w","article-title":"Correlation of oxidative stress-related biomarkers with postmenopausal osteoporosis: a systematic review and meta-analysis","volume":"16","author":"Zhao","year":"2021","journal-title":"Arch. Osteoporos."},{"issue":"11","key":"10.1016\/j.thromres.2023.08.015_bb0075","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11883-017-0678-6","article-title":"Oxidative stress in atherosclerosis","volume":"19","author":"Kattoor","year":"2017","journal-title":"Curr. Atheroscler. Rep."},{"issue":"1","key":"10.1016\/j.thromres.2023.08.015_bb0080","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1021\/acs.est.0c07789","article-title":"Superoxide formation from aqueous reactions of biogenic secondary organic aerosols","volume":"55","author":"Wei","year":"2021","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.thromres.2023.08.015_bb0085","first-page":"292","article-title":"Determination and detection of reactive oxygen species (ROS), lipid peroxidation, and electrolyte leakage in plants","volume":"639","author":"Jambunathan","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.thromres.2023.08.015_bb0090","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-1-0716-0896-8_12","article-title":"EPR spectroscopy as a method for ROS quantification in the skin","volume":"2202","author":"Lohan","year":"2021","journal-title":"Methods Mol. Biol."},{"issue":"10","key":"10.1016\/j.thromres.2023.08.015_bb0095","article-title":"Approaches for reactive oxygen species and oxidative stress quantification in epilepsy","volume":"9","author":"Olowe","year":"2020","journal-title":"Antioxidants (Basel)"},{"issue":"9","key":"10.1016\/j.thromres.2023.08.015_bb0100","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1080\/10837450.2016.1199568","article-title":"Application of EPR spectroscopy to examine free radicals evolution during storage of the thermally sterilized Ungentum ophthalmicum","volume":"23","author":"Ramos","year":"2018","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.thromres.2023.08.015_bb0105","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.yjmcc.2017.07.008","article-title":"Reaction-based small-molecule fluorescent probes for dynamic detection of ROS and transient redox changes in living cells and small animals","volume":"110","author":"Lu","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.thromres.2023.08.015_bb0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-60761-411-1_4","article-title":"Identification of ROS using oxidized DCFDA and flow-cytometry","volume":"594","author":"Eruslanov","year":"2010","journal-title":"Methods Mol. Biol."},{"issue":"11","key":"10.1016\/j.thromres.2023.08.015_bb0115","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1515\/hsz-2017-0152","article-title":"Reactive nitrogen species (RNS)-resistant microbes: adaptation and medical implications","volume":"398","author":"Tharmalingam","year":"2017","journal-title":"Biol. Chem."},{"issue":"5","key":"10.1016\/j.thromres.2023.08.015_bb0120","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1161\/RES.0000000000000110","article-title":"American Heart Association Council on basic cardiovascular, measurement of reactive oxygen species, reactive nitrogen species, and redox-dependent signaling in the cardiovascular system: a scientific statement from the American Heart Association","volume":"119","author":"Griendling","year":"2016","journal-title":"Circ. Res."},{"issue":"1\u20132","key":"10.1016\/j.thromres.2023.08.015_bb0125","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jchromb.2006.07.054","article-title":"Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: appraisal of the Griess reaction in the L-arginine\/nitric oxide area of research","volume":"851","author":"Tsikas","year":"2007","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"8","key":"10.1016\/j.thromres.2023.08.015_bb0130","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1080\/10715760500053651","article-title":"Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological fluids","volume":"39","author":"Tsikas","year":"2005","journal-title":"Free Radic. Res."},{"issue":"1\u20132","key":"10.1016\/j.thromres.2023.08.015_bb0135","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jchromb.2007.02.003","article-title":"Comparison of nitrite\/nitrate concentration in human plasma and serum samples measured by the enzymatic batch Griess assay, ion-pairing HPLC and ion-trap GC-MS: the importance of a correct removal of proteins in the Griess assay","volume":"851","author":"Romitelli","year":"2007","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"2","key":"10.1016\/j.thromres.2023.08.015_bb0140","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/biof.5520340208","article-title":"Lipid peroxidation products as oxidative stress biomarkers","volume":"34","author":"Niki","year":"2008","journal-title":"Biofactors"},{"issue":"14","key":"10.1016\/j.thromres.2023.08.015_bb0145","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1089\/ars.2015.6317","article-title":"Clinical relevance of biomarkers of oxidative stress","volume":"23","author":"Frijhoff","year":"2015","journal-title":"Antioxid. Redox Signal."},{"issue":"10","key":"10.1016\/j.thromres.2023.08.015_bb0150","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1210\/jc.2006-1309","article-title":"Cis-unsaturated fatty acids stimulate reactive oxygen species generation and lipid peroxidation in human spermatozoa","volume":"91","author":"Aitken","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.thromres.2023.08.015_bb0155","doi-asserted-by":"crossref","first-page":"3565127","DOI":"10.1155\/2016\/3565127","article-title":"ROS, cell senescence, and novel molecular mechanisms in aging and age-related diseases","volume":"2016","author":"Davalli","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"12","key":"10.1016\/j.thromres.2023.08.015_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17122078","article-title":"Oxidative stress in hypoxic-ischemic encephalopathy: molecular mechanisms and therapeutic strategies","volume":"17","author":"Zhao","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.thromres.2023.08.015_bb0165","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.imbio.2018.11.010","article-title":"Reactive oxygen species (ROS) in macrophage activation and function in diabetes","volume":"224","author":"Rendra","year":"2019","journal-title":"Immunobiology"},{"issue":"4","key":"10.1016\/j.thromres.2023.08.015_bb0170","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative stress, synaptic dysfunction, and Alzheimer\u2019s disease","volume":"57","author":"Tonnies","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"10","key":"10.1016\/j.thromres.2023.08.015_bb0175","article-title":"Recent updates and advances in Winiwarter-Buerger disease (thromboangiitis obliterans): biomolecular mechanisms, diagnostics and clinical consequences","volume":"11","author":"Fazeli","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.thromres.2023.08.015_bb0180","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jep.2015.01.032","article-title":"Shenfu injection protects human ECV304 cells from hydrogen peroxide via its anti-apoptosis way","volume":"163","author":"Fen-fang","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.thromres.2023.08.015_bb0185","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.atherosclerosis.2017.08.009","article-title":"Pathogenesis of thromboangiitis obliterans: gene polymorphism and immunoregulation of human vascular endothelial cells","volume":"265","author":"Sun","year":"2017","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.thromres.2023.08.015_bb0190","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1161\/ATVBAHA.118.311156","article-title":"Flavorings in tobacco products induce endothelial cell dysfunction","volume":"38","author":"Fetterman","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.thromres.2023.08.015_bb0195","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1124\/jpet.110.169961","article-title":"Stimulation of alpha7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro","volume":"335","author":"Wang","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.thromres.2023.08.015_bb0200","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1084\/jem.146.2.457","article-title":"Activation of factor XII by tobacco glycoprotein","volume":"146","author":"Becker","year":"1977","journal-title":"J. Exp. Med."},{"issue":"17","key":"10.1016\/j.thromres.2023.08.015_bb0205","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMra042354","article-title":"Thrombosis of the cerebral veins and sinuses","volume":"352","author":"Stam","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.thromres.2023.08.015_bb0210","first-page":"217","article-title":"Smoking characteristics and cessation in patients with thromboangiitis obliterans","volume":"65","author":"Jimenez-Ruiz","year":"2006","journal-title":"Monaldi Arch. Chest Dis."},{"issue":"4","key":"10.1016\/j.thromres.2023.08.015_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034717","article-title":"Circulating angiogenic factors in patients with thromboangiitis obliterans","volume":"7","author":"Hewing","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.thromres.2023.08.015_bb0220","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrm3801","article-title":"Cellular mechanisms and physiological consequences of redox-dependent signalling","volume":"15","author":"Holmstrom","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.thromres.2023.08.015_bb0225","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/WOX.0b013e3182439613","article-title":"Oxidative stress and antioxidant defense","volume":"5","author":"Birben","year":"2012","journal-title":"World Allergy Organ. J."},{"key":"10.1016\/j.thromres.2023.08.015_bb0230","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ceb.2014.09.010","article-title":"ROS-dependent signal transduction","volume":"33","author":"Reczek","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"issue":"1","key":"10.1016\/j.thromres.2023.08.015_bb0235","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/cmi.2014.89","article-title":"NADPH oxidases: an overview from structure to innate immunity-associated pathologies","volume":"12","author":"Panday","year":"2015","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.thromres.2023.08.015_bb0240","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.niox.2014.05.014","article-title":"Hydrogen sulfide and nitric oxide interactions in inflammation","volume":"41","author":"Lo Faro","year":"2014","journal-title":"Nitric Oxide"},{"issue":"3","key":"10.1016\/j.thromres.2023.08.015_bb0245","first-page":"199","article-title":"Free radical homeostasis","volume":"35","author":"Fang","year":"2004","journal-title":"Sheng Li Ke Xue Jin Zhan"},{"issue":"15","key":"10.1016\/j.thromres.2023.08.015_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202106252","article-title":"Antithrombotic therapy by regulating the ROS-mediated thrombosis microenvironment and specific nonpharmaceutical thrombolysis using Prussian blue nanodroplets","volume":"18","author":"Zhang","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.thromres.2023.08.015_bb0255","first-page":"794","article-title":"Free radicals and antioxidants in human health: current status and future prospects","volume":"52","author":"Devasagayam","year":"2004","journal-title":"J. Assoc. Physicians India"},{"issue":"6","key":"10.1016\/j.thromres.2023.08.015_bb0260","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/j.1538-7836.2007.02542.x","article-title":"Thalidomide causes platelet activation, which can be abrogated by aspirin","volume":"5","author":"Dunkley","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"22","key":"10.1016\/j.thromres.2023.08.015_bb0265","doi-asserted-by":"crossref","first-page":"35776","DOI":"10.18632\/oncotarget.16205","article-title":"An absence of platelet activation following thalidomide treatment in vitro or in vivo","volume":"8","author":"Qiao","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.thromres.2023.08.015_bb0270","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1111\/j.1538-7836.2004.00952.x","article-title":"Thalidomide, deep venous thrombosis and vasculitis","volume":"2","author":"Silingardi","year":"2004","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2023.08.015_bb0275","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/107602960401000304","article-title":"Erythropoietin-induced thrombosis as a result of increased inflammation and thrombin activatable fibrinolytic inhibitor","volume":"10","author":"Tobu","year":"2004","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"3","key":"10.1016\/j.thromres.2023.08.015_bb0280","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0049-3848(00)00335-2","article-title":"Thrombogenic potential of contrast media in an experimental model of laser-induced thrombosis","volume":"100","author":"Aguejouf","year":"2000","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.thromres.2023.08.015_bb0285","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1006\/bbrc.1995.2036","article-title":"Nonionic contrast agents produce thrombotic effect by inducing adhesion of leukocytes on human endothelium","volume":"212","author":"Abeyama","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.thromres.2023.08.015_bb0290","first-page":"CD012169","article-title":"Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome","volume":"10","author":"Bala","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"15","key":"10.1016\/j.thromres.2023.08.015_bb0295","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1089\/ars.2021.0027","article-title":"Oxidative stress and endothelial dysfunction in sepsis and acute inflammation","volume":"35","author":"Joffre","year":"2021","journal-title":"Antioxid. Redox Signal."},{"issue":"3","key":"10.1016\/j.thromres.2023.08.015_bb0300","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1139\/Y10-015","article-title":"Adventitial fibroblasts in vascular structure and function: the role of oxidative stress and beyond","volume":"88","author":"Di Wang","year":"2010","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"2","key":"10.1016\/j.thromres.2023.08.015_bb0305","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/138920106776597685","article-title":"Oxidative stress on progenitor and stem cells in cardiovascular diseases","volume":"7","author":"Yao","year":"2006","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"6","key":"10.1016\/j.thromres.2023.08.015_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8060166","article-title":"Mitochondrial dysfunction and DNA damage in the context of pathogenesis of atherosclerosis","volume":"8","author":"Shemiakova","year":"2020","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.thromres.2023.08.015_bb0315","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ctrv.2006.05.003","article-title":"Oncological implications of hypoxia inducible factor-1alpha (HIF-1alpha) expression","volume":"32","author":"O\u2019Donnell","year":"2006","journal-title":"Cancer Treat. Rev."},{"issue":"12","key":"10.1016\/j.thromres.2023.08.015_bb0320","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1161\/CIRCRESAHA.107.153346","article-title":"Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia","volume":"101","author":"Bosch-Marce","year":"2007","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.thromres.2023.08.015_bb0325","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1078\/0065-1281-00621","article-title":"Expression of ICAM-1, VCAM-1, E-selectin and TNF-alpha on the endothelium of femoral and iliac arteries in thromboangiitis obliterans","volume":"104","author":"Halacheva","year":"2002","journal-title":"Acta Histochem."},{"issue":"16","key":"10.1016\/j.thromres.2023.08.015_bb0330","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.2174\/0929867322666150429112111","article-title":"Mechanisms of thrombosis, available treatments and management challenges presented by thromboangiitis obliterans","volume":"22","author":"Fazeli","year":"2015","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.thromres.2023.08.015_bb0335","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1076029609336854","article-title":"Effect of eNOS and ET-1 polymorphisms in thromboangiitis obliterans","volume":"16","author":"Adiguzel","year":"2010","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"3","key":"10.1016\/j.thromres.2023.08.015_bb0340","first-page":"2349","article-title":"Cilostazol on the expression of ICAM-1, VCAM-1 and inflammatory factors in plasma in patients with thromboangiitis obliterans","volume":"16","author":"Song","year":"2018","journal-title":"Exp. Ther. Med."},{"issue":"4","key":"10.1016\/j.thromres.2023.08.015_bb0345","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2174\/1570161114666160303111355","article-title":"Increased serum HMGB-1, ICAM-1 and metalloproteinase-9 levels in Buerger\u2019s patients","volume":"14","author":"De Caridi","year":"2016","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.thromres.2023.08.015_bb0350","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cellsig.2018.01.015","article-title":"The IL-6\/STAT3 pathway regulates adhesion molecules and cytoskeleton of endothelial cells in thromboangiitis obliterans","volume":"44","author":"Wei","year":"2018","journal-title":"Cell. Signal."},{"issue":"2","key":"10.1016\/j.thromres.2023.08.015_bb0355","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/1358863X11435979","article-title":"Imbalanced matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 activities in patients with thromboangiitis obliterans","volume":"17","author":"Dellalibera-Joviliano","year":"2012","journal-title":"Vasc. Med."},{"issue":"2","key":"10.1016\/j.thromres.2023.08.015_bb0360","doi-asserted-by":"crossref","first-page":"6715","DOI":"10.4238\/2015.June.18.15","article-title":"Hypoxia-inducible factor-1alpha expression in the different stages of rat thromboangiitis obliterans","volume":"14","author":"He","year":"2015","journal-title":"Genet. Mol. Res."},{"issue":"2","key":"10.1016\/j.thromres.2023.08.015_bb0365","first-page":"197","article-title":"The status of nitric oxide and its backup, heme oxygenase 1, in thromboangiitis obliterans","volume":"6","author":"Aliee","year":"2018","journal-title":"Rep. Biochem. Mol. Biol."},{"key":"10.1016\/j.thromres.2023.08.015_bb0370","doi-asserted-by":"crossref","first-page":"1018438","DOI":"10.3389\/fphar.2022.1018438","article-title":"Baiying qingmai formulation ameliorates thromboangiitis obliterans by inhibiting HMGB1\/RAGE\/NF-kappaB signaling pathways","volume":"13","author":"Zou","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.thromres.2023.08.015_bb0375","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.bbrc.2018.09.002","article-title":"Alleviation of A disintegrin and metalloprotease 10 (ADAM10) on thromboangiitis obliterans involves the HMGB1\/RAGE\/NF-kappaB pathway","volume":"505","author":"Liu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.thromres.2023.08.015_bb0380","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s13023-019-1166-6","article-title":"Angiogenesis induction in Buerger's disease: a disease management double-edged sword?","volume":"14","author":"Fazeli","year":"2019","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.thromres.2023.08.015_bb0385","doi-asserted-by":"crossref","first-page":"9759735","DOI":"10.1155\/2017\/9759735","article-title":"Markers and biomarkers of endothelium: when something is rotten in the state","volume":"2017","author":"Goncharov","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.thromres.2023.08.015_bb0390","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.toxlet.2017.11.031","article-title":"Protective effects of dioscin against fructose-induced renal damage via adjusting Sirt3-mediated oxidative stress, fibrosis, lipid metabolism and inflammation","volume":"284","author":"Qiao","year":"2018","journal-title":"Toxicol. Lett."},{"issue":"8","key":"10.1016\/j.thromres.2023.08.015_bb0395","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2174\/1389203723666220823151326","article-title":"Structure, distribution, regulation, and function of splice variant isoforms of nitric oxide synthase family in the nervous system","volume":"23","author":"Hosseini","year":"2022","journal-title":"Curr. Protein Pept. Sci."},{"issue":"2","key":"10.1016\/j.thromres.2023.08.015_bb0400","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1152\/physrev.00042.2007","article-title":"eNOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues","volume":"89","author":"Balligand","year":"2009","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.thromres.2023.08.015_bb0405","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/01.ATV.0000110785.96039.f6","article-title":"Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease","volume":"24","author":"Alp","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.thromres.2023.08.015_bb0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.redox.2012.11.003","article-title":"Nitrosative stress and redox-cycling agents synergize to cause mitochondrial dysfunction and cell death in endothelial cells","volume":"1","author":"Diers","year":"2013","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.thromres.2023.08.015_bb0415","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1177\/1076029606293429","article-title":"Stromelysin-1 5A\/6A and eNOS T-786C polymorphisms, MTHFR C677T and A1298C mutations, and cigarette-cannabis smoking: a pilot, hypothesis-generating study of gene-environment pathophysiological associations with Buerger\u2019s disease","volume":"12","author":"Glueck","year":"2006","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"24","key":"10.1016\/j.thromres.2023.08.015_bb0420","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.thromres.2023.08.015_bb0425","first-page":"209","article-title":"Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease","volume":"103","author":"Benjamin","year":"2012","journal-title":"Exp. Suppl."},{"issue":"6","key":"10.1016\/j.thromres.2023.08.015_bb0430","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/019021490944232","article-title":"Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology","volume":"31","author":"Chakrabarti","year":"2005","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.thromres.2023.08.015_bb0435","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/nyas.12048","article-title":"The role of autoimmunity in thromboangiitis obliterans (Buerger\u2019s disease)","volume":"1285","author":"Ketha","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.thromres.2023.08.015_bb0440","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1161\/CIRCULATIONAHA.111.060335","article-title":"Nonatherosclerotic arterial disorders of the lower extremities","volume":"126","author":"Weinberg","year":"2012","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.thromres.2023.08.015_bb0445","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.atherosclerosis.2014.04.026","article-title":"The effect of physical activity or exercise on key biomarkers in atherosclerosis\u2014a systematic review","volume":"235","author":"Palmefors","year":"2014","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.thromres.2023.08.015_bb0450","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.4049\/jimmunol.1100646","article-title":"ICAM-1: getting a grip on leukocyte adhesion","volume":"186","author":"Long","year":"2011","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.thromres.2023.08.015_bb0455","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1083\/jcb.200112126","article-title":"Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes","volume":"157","author":"Barreiro","year":"2002","journal-title":"J. Cell Biol."},{"issue":"6","key":"10.1016\/j.thromres.2023.08.015_bb0460","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2362.2010.02294.x","article-title":"Thromboangiitis obliterans and endothelial function","volume":"40","author":"Azizi","year":"2010","journal-title":"Eur. J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.thromres.2023.08.015_bb0465","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCRESAHA.115.307674","article-title":"NSun2 deficiency protects endothelium from inflammation via mRNA methylation of ICAM-1","volume":"118","author":"Luo","year":"2016","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.thromres.2023.08.015_bb0470","first-page":"219","article-title":"Cytokine production in thromboangiitis obliterans patients: new evidence for an immune-mediated inflammatory disorder","volume":"23","author":"Slavov","year":"2005","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2","key":"10.1016\/j.thromres.2023.08.015_bb0475","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.atherosclerosis.2009.01.042","article-title":"Thromboangiitis obliterans in the 21st century\u2014a new face of disease","volume":"206","author":"Malecki","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.thromres.2023.08.015_bb0480","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.760331","article-title":"Active flavonoids from Lagotis brachystachya attenuate monosodium urate-induced gouty arthritis via inhibiting TLR4\/MyD88\/NF-kappaB pathway and NLRP3 expression","volume":"12","author":"Ouyang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.thromres.2023.08.015_bb0485","doi-asserted-by":"crossref","first-page":"7304096","DOI":"10.1155\/2018\/7304096","article-title":"Levistilide a ameliorates NLRP3 expression involving the Syk-p38\/JNK pathway and peripheral obliterans in rats","volume":"2018","author":"Guo","year":"2018","journal-title":"Mediat. Inflamm."},{"issue":"12","key":"10.1016\/j.thromres.2023.08.015_bb0490","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1007\/s00380-017-1059-3","article-title":"Tumor necrosis factor alpha-stimulated gene-6 (TSG-6) inhibits the inflammatory response by inhibiting the activation of P38 and JNK signaling pathway and decreases the restenosis of vein grafts in rats","volume":"32","author":"Zhang","year":"2017","journal-title":"Heart Vessel."},{"issue":"11","key":"10.1016\/j.thromres.2023.08.015_bb0495","first-page":"4051","article-title":"ADAM10 inhibits the interaction between IL-17 and HMGB1 in Buerger\u2019s disease","volume":"25","author":"Byun","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.thromres.2023.08.015_bb0500","first-page":"3947","article-title":"Effect of revascularization on IL-6 and TNF-alpha in patients with thromboangiitis obliterans","volume":"15","author":"Wu","year":"2018","journal-title":"Exp. Ther. Med."},{"issue":"3","key":"10.1016\/j.thromres.2023.08.015_bb0505","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/1708538113477068","article-title":"Investigation of the expression of mediators of neovascularization from mononuclear leukocytes in thromboangiitis obliterans","volume":"22","author":"Fazeli","year":"2014","journal-title":"Vascular"},{"issue":"1","key":"10.1016\/j.thromres.2023.08.015_bb0510","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12929-019-0550-9","article-title":"Cilostazol inhibits hyperglucose-induced vascular smooth muscle cell dysfunction by modulating the RAGE\/ERK\/NF-kappaB signaling pathways","volume":"26","author":"Su","year":"2019","journal-title":"J. Biomed. Sci."},{"issue":"5","key":"10.1016\/j.thromres.2023.08.015_bb0515","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/med.21396","article-title":"The Keap1-Nrf2-ARE pathway as a potential preventive and therapeutic target: an update","volume":"36","author":"Lu","year":"2016","journal-title":"Med. Res. Rev."},{"issue":"3","key":"10.1016\/j.thromres.2023.08.015_bb0520","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.freeradbiomed.2012.04.019","article-title":"Functional dissection of Nrf2-dependent phase II genes in vascular inflammation and endotoxic injury using Keap1 siRNA","volume":"53","author":"Kim","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.thromres.2023.08.015_bb0525","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1161\/01.ATV.0000258868.80079.4d","article-title":"Nrf2 gene transfer induces antioxidant enzymes and suppresses smooth muscle cell growth in vitro and reduces oxidative stress in rabbit aorta in vivo","volume":"27","author":"Levonen","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.thromres.2023.08.015_bb0530","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/gerona\/glr092","article-title":"Age-associated vascular oxidative stress, Nrf2 dysfunction, and NF-kappaB activation in the nonhuman primate Macaca mulatta","volume":"66","author":"Ungvari","year":"2011","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"3","key":"10.1016\/j.thromres.2023.08.015_bb0535","doi-asserted-by":"crossref","first-page":"261","DOI":"10.23736\/S0392-9590.20.04327-8","article-title":"Cotinine aggravates inflammatory response in thromboangiitis obliterans through TLR-4\/MyD88\/NF-kappaB inflammatory signaling pathway","volume":"39","author":"Shi","year":"2020","journal-title":"Int. Angiol."},{"issue":"1","key":"10.1016\/j.thromres.2023.08.015_bb0540","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jvs.2012.06.083","article-title":"High-mobility-group box protein 1A box reduces development of sodium laurate-induced thromboangiitis obliterans in rats","volume":"57","author":"Kong","year":"2013","journal-title":"J. Vasc. Surg."},{"issue":"20","key":"10.1016\/j.thromres.2023.08.015_bb0545","first-page":"10605","article-title":"MiR-223 alleviates thrombus and inflammation in thromboangiitis obliterans rats by regulating NLRP3","volume":"24","author":"Zhou","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.thromres.2023.08.015_bb0550","first-page":"7","article-title":"The relationship of haemostatic system to the vessel wall, thromboembolism, atherosclerosis from pathogenesis and laboratory standpoints","volume":"19","author":"Ulutin","year":"2002","journal-title":"Turk. J. Haematol."},{"issue":"2","key":"10.1016\/j.thromres.2023.08.015_bb0555","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41584-018-0145-y","article-title":"Pathogenesis and therapeutic interventions for ANCA-associated vasculitis","volume":"15","author":"Nakazawa","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.thromres.2023.08.015_bb0560","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/1708538121989854","article-title":"miR-100 alleviates the inflammatory damage and apoptosis of H(2)O(2)-induced human umbilical vein endothelial cells via inactivation of Notch signaling by targeting MMP9","volume":"30","author":"Wang","year":"2022","journal-title":"Vascular"},{"issue":"2","key":"10.1016\/j.thromres.2023.08.015_bb0565","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00595-013-0566-9","article-title":"Possible involvement of Notch signaling in the pathogenesis of Buerger\u2019s disease","volume":"44","author":"Tamai","year":"2014","journal-title":"Surg. Today"},{"issue":"6","key":"10.1016\/j.thromres.2023.08.015_bb0570","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/1708538113478742","article-title":"Study about correlation of anti-neutrophil cytoplasmic antibodies and anticardiolipin antibodies with thromboangiitis obliterans","volume":"21","author":"Guo","year":"2013","journal-title":"Vascular"},{"issue":"4","key":"10.1016\/j.thromres.2023.08.015_bb0575","doi-asserted-by":"crossref","first-page":"250","DOI":"10.5455\/aim.2013.21.250-252","article-title":"Periodontitis and Buerger\u2019s disease: recent advances","volume":"21","author":"Pavlic","year":"2013","journal-title":"Acta Inform. Med."},{"issue":"8","key":"10.1016\/j.thromres.2023.08.015_bb0580","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S1286-4579(00)00391-9","article-title":"The oral cavity as a reservoir of bacterial pathogens for focal infections","volume":"2","author":"Gendron","year":"2000","journal-title":"Microbes Infect."},{"issue":"5","key":"10.1016\/j.thromres.2023.08.015_bb0585","doi-asserted-by":"crossref","first-page":"410","DOI":"10.23736\/S0392-9590.17.03420-4","article-title":"Rickettsia infection could be the missing piece of the Buerger\u2019s disease puzzle","volume":"36","author":"Fazeli","year":"2017","journal-title":"Int. Angiol."},{"issue":"1","key":"10.1016\/j.thromres.2023.08.015_bb0590","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3947\/ic.2021.0146","article-title":"Buerger\u2019s disease may be a chronic Rickettsial infection with superimposed thrombosis: literature review and efficacy of doxycycline in three patients","volume":"54","author":"Chung","year":"2022","journal-title":"Infect. Chemother."},{"key":"10.1016\/j.thromres.2023.08.015_bb0595","first-page":"33","article-title":"Detection of Rickettsia endosymbiont Bemisia tabaci in the amputated limbs of three Buerger\u2019s disease patients","volume":"13","author":"Fazeli","year":"2020","journal-title":"Int. Med. Case Rep. J."},{"issue":"6","key":"10.1016\/j.thromres.2023.08.015_bb0600","first-page":"489","article-title":"Trace elements and toxic heavy metals play a role in Buerger disease and atherosclerotic peripheral arterial occlusive disease","volume":"29","author":"Arslan","year":"2010","journal-title":"Int. Angiol."},{"issue":"4","key":"10.1016\/j.thromres.2023.08.015_bb0605","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.avsg.2008.11.006","article-title":"The role of oxidative stress and antioxidant defenses in Buerger disease and atherosclerotic peripheral arterial occlusive disease","volume":"24","author":"Arslan","year":"2010","journal-title":"Ann. Vasc. Surg."},{"issue":"11","key":"10.1016\/j.thromres.2023.08.015_bb0610","first-page":"1034","article-title":"The role of folic acid on the hyperhomocysteinemia in the Buerger\u2019s disease (thromboangiitis obliterans)","volume":"19","author":"Beigi","year":"2014","journal-title":"J. Res. Med. Sci."},{"issue":"6","key":"10.1016\/j.thromres.2023.08.015_bb0615","first-page":"5041","article-title":"Effects of aspirin combined with cilostazol on thromboangiitis obliterans in diabetic patients","volume":"16","author":"Yong","year":"2018","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.thromres.2023.08.015_bb0620","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/00003495-200262010-00005","article-title":"Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension","volume":"62","author":"Melian","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.thromres.2023.08.015_bb0625","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.freeradbiomed.2012.09.013","article-title":"Bosentan inhibits oxidative and nitrosative stress and rescues occlusive pulmonary hypertension","volume":"56","author":"Rafikova","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.thromres.2023.08.015_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.avsg.2010.11.012","article-title":"Compartment syndrome as a rare complication of iloprost infusion for peripheral vascular disease","volume":"25","author":"Thomas","year":"2011","journal-title":"Ann. Vasc. Surg."},{"issue":"5","key":"10.1016\/j.thromres.2023.08.015_bb0635","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1160\/TH07-08-0509","article-title":"The prostacyclin analogue iloprost increases circulating endothelial progenitor cells in patients with critical limb ischemia","volume":"100","author":"Di Stefano","year":"2008","journal-title":"Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.thromres.2023.08.015_bb0640","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/hq1001.097065","article-title":"Chronic blockade of endothelin receptors improves ischemia-induced angiogenesis in rat hindlimbs through activation of vascular endothelial growth factor-no pathway","volume":"21","author":"Iglarz","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.thromres.2023.08.015_bb0645","doi-asserted-by":"crossref","first-page":"H2066","DOI":"10.1152\/ajpheart.00147.2005","article-title":"PGE1 analog alprostadil induces VEGF and eNOS expression in endothelial cells","volume":"289","author":"Haider","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.thromres.2023.08.015_bb0650","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejvs.2011.07.015","article-title":"Cilostazol stimulates revascularisation in response to ischaemia via an eNOS-dependent mechanism","volume":"43","author":"Hori","year":"2012","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"issue":"6","key":"10.1016\/j.thromres.2023.08.015_bb0655","first-page":"CD003748","article-title":"Cilostazol for intermittent claudication","volume":"6","author":"Brown","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.thromres.2023.08.015_bb0660","article-title":"Do patients with arterial occlusive disease of different etiologies benefit equally from cilostazol?","volume":"50","author":"Depboylu","year":"2023","journal-title":"Tex. Heart Inst. J."},{"issue":"4","key":"10.1016\/j.thromres.2023.08.015_bb0665","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/1756-185X.14573","article-title":"Thromboangiitis obliterans and foot necrosis: a case of successful treatment with alprostadil","volume":"26","author":"Silva","year":"2023","journal-title":"Int. J. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.thromres.2023.08.015_bb0670","first-page":"420","article-title":"The wound healing effects of Iloprost in patients with Buerger\u2019s disease: claudication and prevention of major amputations","volume":"13","author":"Afsharfard","year":"2011","journal-title":"Iran Red Crescent Med J"},{"issue":"2","key":"10.1016\/j.thromres.2023.08.015_bb0675","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5761\/atcs.oa.11.01868","article-title":"A stable prostacyclin analogue (iloprost) in the treatment of Buerger\u2019s disease: a prospective analysis of 150 patients","volume":"19","author":"Bozkurt","year":"2013","journal-title":"Ann. Thorac. Cardiovasc. Surg."},{"issue":"2","key":"10.1016\/j.thromres.2023.08.015_bb0680","first-page":"150","article-title":"Efficacy of intravenous iloprost (Ilomedin(R)) in salvage of the only extremity in a patient with thrombangiitis obliterans","volume":"20","author":"Gaisin","year":"2014","journal-title":"Angiol Sosud Khir"},{"key":"10.1016\/j.thromres.2023.08.015_bb0685","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2261-12-5","article-title":"Treatment of thromboangiitis obliterans (Buerger\u2019s disease) with bosentan","volume":"12","author":"De Haro","year":"2012","journal-title":"BMC Cardiovasc. Disord."},{"issue":"48","key":"10.1016\/j.thromres.2023.08.015_bb0690","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005511","article-title":"Efficacy of bosentan in patients with refractory thromboangiitis obliterans (Buerger disease): a case series and review of the literature","volume":"95","author":"Narvaez","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.thromres.2023.08.015_bb0695","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2174\/1570161119666210118125424","article-title":"Outcomes of anticoagulant therapy with low-molecular-weight heparin (LMWH) and warfarin for thromboangiitis obliterans (TAO)","volume":"19","author":"Gao","year":"2021","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.thromres.2023.08.015_bb0700","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-219111","article-title":"Cannabis arteritis: ever more important to consider","volume":"2017","author":"Santos","year":"2017","journal-title":"BMJ Case Rep."},{"issue":"2","key":"10.1016\/j.thromres.2023.08.015_bb0705","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jep.2011.09.033","article-title":"Protective effect of Shenfu injection on thromboangiitis obliterans model rats","volume":"138","author":"Hong","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.thromres.2023.08.015_bb0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154709","article-title":"Integrated pharmacokinetics and pharmacometabolomics to reveal the synergistic mechanism of a multicomponent Chinese patent medicine, Mailuo Shutong pills against thromboangiitis obliterans","volume":"112","author":"Wang","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.thromres.2023.08.015_bb0715","article-title":"Therapeutic effect and mechanism of Si-Miao-Yong-An-Tang on thromboangiitis obliterans based on the urine metabolomics approach","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.thromres.2023.08.015_bb0720","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11655-023-3630-3","article-title":"Protective effects and potential mechanism of tongxinluo on mice with thromboangiitis obliterans induced by sodium laurate","volume":"29","author":"Gu","year":"2023","journal-title":"Chin. J. Integr. Med."},{"issue":"8689","key":"10.1016\/j.thromres.2023.08.015_bb0725","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0140-6736(90)90346-7","article-title":"Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO study","volume":"335","author":"Fiessinger","year":"1990","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.thromres.2023.08.015_bb0730","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S1078-5884(98)80032-4","article-title":"Oral iloprost in the treatment of thromboangiitis obliterans (Buerger's disease): a double-blind, randomised, placebo-controlled trial. The European TAO Study Group","volume":"15","year":"1998","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"issue":"12","key":"10.1016\/j.thromres.2023.08.015_bb0735","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/bjs.8895","article-title":"Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication","volume":"99","author":"Stevens","year":"2012","journal-title":"Br. J. Surg."},{"issue":"1","key":"10.1016\/j.thromres.2023.08.015_bb0740","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.4238\/2014.March.17.2","article-title":"Embolus-carried vascular endothelial cell growth factor 165 improves angiogenesis in thromboangiitis obliterans","volume":"13","author":"Liu","year":"2014","journal-title":"Genet. Mol. Res."},{"issue":"4","key":"10.1016\/j.thromres.2023.08.015_bb0745","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/1708538113502648","article-title":"Thromboangiitis obliterans successfully treated with phosphodiesterase type 5 inhibitors","volume":"22","author":"Abeles","year":"2014","journal-title":"Vascular"},{"issue":"1","key":"10.1016\/j.thromres.2023.08.015_bb0750","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejvs.2009.02.005","article-title":"Selective and sustained delivery of basic fibroblast growth factor (bFGF) for treatment of peripheral arterial disease: results of a phase I trial","volume":"38","author":"Hashimoto","year":"2009","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"issue":"5","key":"10.1016\/j.thromres.2023.08.015_bb0755","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00380-015-0677-x","article-title":"Safety and efficacy of sustained release of basic fibroblast growth factor using gelatin hydrogel in patients with critical limb ischemia","volume":"31","author":"Kumagai","year":"2016","journal-title":"Heart Vessel."},{"key":"10.1016\/j.thromres.2023.08.015_bb0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.153110","article-title":"Protective effects and potential mechanism of salvianolic acid B on sodium laurate-induced thromboangiitis obliterans in rats","volume":"66","author":"Zhang","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.thromres.2023.08.015_bb0765","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jep.2018.05.008","article-title":"Anti-inflammatory activities and potential mechanisms of phenolic acids isolated from Salvia miltiorrhiza f. alba roots in THP-1 macrophages","volume":"222","author":"Liu","year":"2018","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.thromres.2023.08.015_bb0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116180","article-title":"Jia-Wei-Si-Miao-Yong-An Fang stimulates the healing of acute radiation-induced cutaneous wounds through MAPK\/ERK pathway","volume":"306","author":"Wang","year":"2023","journal-title":"J. Ethnopharmacol."},{"issue":"18","key":"10.1016\/j.thromres.2023.08.015_bb0775","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.21037\/atm-21-3752","article-title":"Integration of traditional Chinese medicine and nibble debridement and dressing method reduces thrombosis and inflammatory response in the treatment of thromboangiitis obliterans","volume":"9","author":"Li","year":"2021","journal-title":"Ann. Transl. Med."},{"issue":"1","key":"10.1016\/j.thromres.2023.08.015_bb0780","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0254-6272(15)30007-8","article-title":"Integrated treatment for lower-limb stage II thromboangiitis obliterans by interventional therapy and oral administration of Chinese medicine: a randomized controlled clinical trial","volume":"35","author":"Chang","year":"2015","journal-title":"J. Tradit. Chin. Med."},{"issue":"4","key":"10.1016\/j.thromres.2023.08.015_bb0785","doi-asserted-by":"crossref","first-page":"713","DOI":"10.5603\/KP.a2018.0071","article-title":"Oxidative stress and cardiovascular disease: new insights","volume":"76","author":"Pignatelli","year":"2018","journal-title":"Kardiol. Pol."},{"key":"10.1016\/j.thromres.2023.08.015_bb0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154313","article-title":"Identifying quality markers of Mailuoshutong pill against thromboangiitis obliterans based on chinmedomics strategy","volume":"104","author":"Chu","year":"2022","journal-title":"Phytomedicine"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823002487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823002487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:52:02Z","timestamp":1758736322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384823002487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":158,"alternative-id":["S0049384823002487"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.08.015","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances of oxidative stress in thromboangiitis obliterans: biomolecular mechanisms, biomarkers, sources and clinical applications","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}